Healthcare provider profile · identity verified

Daniel Jeung, MD

Internal Medicine · YPSILANTI, MI · NPI 1417375452

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1160	336
Amlodipine Besylate	Amlodipine Besylate	712	211
Lisinopril	Lisinopril	492	149
Levothyroxine Sodium	Levothyroxine Sodium	441	120
Metformin Hcl	Metformin Hcl	376	121
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	352	67
Metoprolol Succinate	Metoprolol Succinate	286	82
Tamsulosin Hcl	Tamsulosin Hcl	279	81
Losartan Potassium	Losartan Potassium	267	88
Eliquis	Apixaban	258	73
Omeprazole	Omeprazole	220	81
Gabapentin	Gabapentin	198	65
Furosemide	Furosemide	191	69
Jardiance	Empagliflozin	185	49
Hydrochlorothiazide	Hydrochlorothiazide	183	60
Rosuvastatin Calcium	Rosuvastatin Calcium	171	52
Trazodone Hcl	Trazodone Hcl	164	54
Spironolactone	Spironolactone	159	45
Carvedilol	Carvedilol	143	50
Allopurinol	Allopurinol	129	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	125	36
Simvastatin	Simvastatin	125	34
Glimepiride	Glimepiride	119	30
Albuterol Sulfate Hfa	Albuterol Sulfate	118	51
Pravastatin Sodium	Pravastatin Sodium	114	34
Sertraline Hcl	Sertraline Hcl	113	37
Alendronate Sodium	Alendronate Sodium	109	36
Fluticasone Propionate	Fluticasone Propionate	108	40
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	107	37
Trulicity	Dulaglutide	105	22
Metoprolol Tartrate	Metoprolol Tartrate	103	24
Famotidine	Famotidine	102	33
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	91	24
Atenolol	Atenolol	89	24
Fluoxetine Hcl	Fluoxetine Hcl	88	24
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	83	16
Tramadol Hcl	Tramadol Hcl	79	18
Potassium Chloride	Potassium Chloride	77	26
Clopidogrel	Clopidogrel Bisulfate	75	28
Duloxetine Hcl	Duloxetine Hcl	75	28
Finasteride	Finasteride	75	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	75	19
Ezetimibe	Ezetimibe	74	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	72	37
Escitalopram Oxalate	Escitalopram Oxalate	71	24
Chlorthalidone	Chlorthalidone	70	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	70	17
Pantoprazole Sodium	Pantoprazole Sodium	70	27
Metformin Hcl Er	Metformin Hcl	69	28
Montelukast Sodium	Montelukast Sodium	68	20
Rybelsus	Semaglutide	66	15
Doxazosin Mesylate	Doxazosin Mesylate	62	14
Ozempic	Semaglutide	55	12
Valsartan	Valsartan	55	19
Glipizide	Glipizide	54	13
Propranolol Hcl Er	Propranolol Hcl	53	12
Venlafaxine Hcl Er	Venlafaxine Hcl	49	17
Warfarin Sodium	Warfarin Sodium	49	13
Ibuprofen	Ibuprofen	48	25
Indapamide	Indapamide	47	16
Nortriptyline Hcl	Nortriptyline Hcl	46	14
Oxybutynin Chloride Er	Oxybutynin Chloride	46	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	42	31
Donepezil Hcl	Donepezil Hcl	41	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Lidocaine	Lidocaine	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	12
Bumetanide	Bumetanide	38	15
Olmesartan Medoxomil	Olmesartan Medoxomil	38	12
Alprazolam	Alprazolam	37	15
Klor-Con M20	Potassium Chloride	37	suppressed
Meloxicam	Meloxicam	37	13
Colchicine	Colchicine	35	19
Bupropion Xl	Bupropion Hcl	34	suppressed
Irbesartan	Irbesartan	34	suppressed
Mirtazapine	Mirtazapine	34	16
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	34	14
Buspirone Hcl	Buspirone Hcl	33	suppressed
Clonazepam	Clonazepam	33	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	33	12
Mounjaro	Tirzepatide	32	suppressed
Ventolin Hfa	Albuterol Sulfate	32	suppressed
Xarelto	Rivaroxaban	30	11
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Prednisone	Prednisone	27	22
Pregabalin	Pregabalin	26	11
Januvia	Sitagliptin Phosphate	24	suppressed
Ketoconazole	Ketoconazole	24	17
Nitroglycerin	Nitroglycerin	24	20
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	21
Baclofen	Baclofen	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	22	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	22	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Naproxen	Naproxen	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Fluconazole	Fluconazole	17	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Eplerenone	Eplerenone	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Entresto	Sacubitril/Valsartan	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Azithromycin	Azithromycin	13	13
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Tiotropium Bromide	Tiotropium Bromide	13	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	12	suppressed
Butorphanol Tartrate	Butorphanol Tartrate	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	12
Lorazepam	Lorazepam	12	suppressed
Risedronate Sodium	Risedronate Sodium	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Tadalafil	Tadalafil	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Torsemide	Torsemide	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error